Key result
Metabolic syndrome and known diabetes were associated with increased odds of depressiveness (OR 2.0, 95% CI 1.3-2.6 and OR 4.2, 95% CI 2.3-7.8, respectively) compared to subjects without.
Why the study?
Is metabolic syndrome and known type 2 diabetes mellitus associated with an increased prevalence of depression and anxiety in adults?
Cross-Sectional (n=2,111)
Is metabolic syndrome and known type 2 diabetes mellitus associated with an increased prevalence of depression and anxiety in adults?
Effect estimate: OR 2.0 (95% CI 1.3-2.6)
p-value: p=<0.001
Metabolic syndrome and known type 2 diabetes are associated with a significantly higher prevalence of depression and anxiety in adults.
No takes yet. Share an insight, caveat, or question.
Association warrants no practice change; leaves open prospective studies on depression risk in metabolic syndrome and diabetes.
Shinkov et al. (2017) conducted a cross-sectional in Metabolic syndrome and type 2 diabetes mellitus (n=2,111). Metabolic syndrome vs. Without metabolic syndrome was evaluated on Depressiveness (OR 2.0, 95% CI 1.3-2.6, p=<0.001). Metabolic syndrome and known diabetes were associated with increased odds of depressiveness (OR 2.0, 95% CI 1.3-2.6 and OR 4.2, 95% CI 2.3-7.8, respectively) compared to subjects without.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: